KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 116 filers reported holding KURA ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,273,000 | +100.2% | 139,462 | +6.5% | 0.02% | +87.5% |
| Q2 2020 | $2,134,000 | -8.6% | 130,898 | -44.2% | 0.01% | -38.5% |
| Q1 2020 | $2,334,000 | +1.8% | 234,560 | +40.6% | 0.01% | +8.3% |
| Q4 2019 | $2,293,000 | +696.2% | 166,774 | +778.0% | 0.01% | +500.0% |
| Q3 2019 | $288,000 | -23.0% | 18,994 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $374,000 | +16.9% | 18,994 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $320,000 | – | 19,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |